Positron emission tomography in lung cancer

Area of Science:

• Nuclear Medicine
• Oncology
• Radiology

Background:

• Positron emission tomography (PET) using 2-deoxy-2-fluoro-D-glucose (FDG) has advanced lung cancer diagnosis, staging, and malignancy grading.
• Despite its utility, FDG-PET imaging presents several challenges and limitations in the clinical management of lung cancer.

Purpose of the Study:

• To review the pitfalls associated with FDG-PET imaging in various aspects of lung cancer management.
• To provide insights for the effective clinical utilization of FDG-PET in lung cancer diagnosis and treatment.

Main Methods:

• Literature review focusing on the limitations of FDG-PET in lung cancer.
• Analysis of pitfalls in diagnosis of pulmonary nodules, semiquantitative analysis, N-staging, and prediction of treatment response.

Main Results:

• FDG-PET has known limitations in diagnosing pulmonary nodules and assessing tumor aggressiveness.
• Challenges exist in semiquantitative analysis of FDG uptake, N-staging accuracy, and predicting treatment response.
• Understanding these pitfalls is crucial for accurate interpretation and clinical decision-making.

Conclusions:

• Effective clinical use of FDG-PET in lung cancer requires awareness and mitigation of its inherent pitfalls.
• Further research and standardized protocols may improve the reliability and accuracy of FDG-PET in lung cancer management.